Hubei Gedian Humanwell Pharmaceutical Testosterone Hubei Gedian Humanwell Pharmaceutical Testosterone

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Testosterone on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
448
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • FILM, EXTENDED RELEASE;TRANSDERMAL - 2MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • FILM, EXTENDED RELEASE;TRANSDERMAL - 4MG/24HR **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • GEL, METERED;NASAL - 5.5MG/0.122GM ACTUATION
  • GEL, METERED;TRANSDERMAL - 12.5MG/1.25GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • GEL;TRANSDERMAL - 25MG/2.5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • GEL;TRANSDERMAL - 50MG/5GM PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • GEL;TRANSDERMAL - 50MG/5GM PACKET
  • TABLET, EXTENDED RELEASE;BUCCAL - 30MG
  • GEL, METERED;TRANSDERMAL - 1.62% (20.25MG/1.25GM ACTUATION)
  • GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • SOLUTION, METERED;TRANSDERMAL - 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
8877230
2024-02-04
U-1616
205488
NASAL ADMINISTRATION OF A TESTOSTERONE GEL TO A PATIENT TO TREAT THE PATIENT FOR A CONDITION ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TES
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
8574622
Y
2024-02-04
205488
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
8784869
Y
2024-02-04
205488
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
8784882
Y
2024-02-04
U-1557
205488
A METHOD OF TESTOSTERONE REPLACEMENT THERAPY COMPRISING THE STEP OF NASALLY ADMINISTERING TO A PATIENT IN NEED OF SUCH TREATMENT AN EFFECTIVE AMOUNT O
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
11090312
2034-03-17
U-1616
205488
NASAL ADMINISTRATION OF A TESTOSTERONE GEL TO A PATIENT TO TREAT THE PATIENT FOR A CONDITION ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TES
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8486925
Y
2026-10-12
22309
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8729057
Y
2026-10-12
22309
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8486925
Y
2026-10-12
22309
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8729057
Y
2026-10-12
22309
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8754070
Y
2026-10-12
22309
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8759329
Y
2026-10-12
22309
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8741881
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466136
Y
2026-10-12
22309
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8754070
Y
2026-10-12
22309
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466137
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8486925
Y
2026-10-12
22309
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8741881
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8754070
Y
2026-10-12
22309
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8741881
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466136
Y
2026-10-12
22309
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466137
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466137
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8729057
Y
2026-10-12
22309
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466138
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466138
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466136
Y
2026-10-12
22309
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8759329
Y
2026-10-12
22309
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8466138
2026-10-12
U-1103
22309
TESTOSTERONE REPLACEMENT THERAPY IN MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8759329
Y
2026-10-12
22309
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8807861
Y
2027-02-26
U-1563
22504
A METHOD OF TRANSDERMAL ADMINISTRATION OF A PHYSIOLOGICALLY ACTIVE AGENT TO A SUBJECT.
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8419307
2027-02-26
U-1386
22504
A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF A PERSON IN NEED THEREOF
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9180194
2026-06-02
U-1390
22504
A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9289586
2027-02-26
U-1390
22504
A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8993520
2026-06-02
U-1390
22504
A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8435944
2027-09-27
U-1390
22504
A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9295675
Y
2034-02-11
U-1531
204399
METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9662340
Y
2034-02-11
U-1531
204399
METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9295675
Y
2034-02-11
U-1531
204399
METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8785426
Y
2034-02-11
U-1531
204399
METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8785426
Y
2034-02-11
U-1531
204399
METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9662340
Y
2034-02-11
U-1531
204399
METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY